Home > Publications database > Dietary and circulating fatty acids and ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. > print

001     156859
005     20240229123119.0
024 7 _ |a 10.1158/1055-9965.EPI-19-1477
|2 doi
024 7 _ |a pmid:32616494
|2 pmid
024 7 _ |a 1055-9965
|2 ISSN
024 7 _ |a 1538-7755
|2 ISSN
024 7 _ |a altmetric:85105905
|2 altmetric
037 _ _ |a DKFZ-2020-01176
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Yammine, Sahar
|b 0
245 _ _ |a Dietary and circulating fatty acids and ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition.
260 _ _ |a Philadelphia, Pa.
|c 2020
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1602762150_3285
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2020 Sep;29(9):1739-1749
520 _ _ |a Fatty acids impact obesity, estrogens and inflammation, risk factors for ovarian cancer. Few epidemiological studies have investigated the association of fatty acids with ovarian cancer.Within the European Prospective Investigation into Cancer and nutrition, 1,486 incident ovarian cancer cases were identified. Cox Proportional Hazard models with adjustment for ovarian cancer risk factors were used to estimate hazard ratios of ovarian cancer across quintiles of intake of fatty acids. False discovery rate was computed to control for multiple testing. Multivariable conditional logistic regression models were used to estimate odds ratios of ovarian cancer across tertiles of plasma fatty acids among 633 cases and two matched controls in a nested case-control analysis.A positive association was found between ovarian cancer and intake of industrial trans elaidic acid (Hazard Ratio comparing 5th with 1st quintileQ5-Q1=1.29; 95% CI=1.03-1.62; ptrend=0.02, q-value=0.06). Dietary intakes of n-6 linoleic acid (HRQ5-Q1=1.10; 95% CI=1.01-1.21; ptrend=0.03) and n-3 α-linolenic acid (HRQ5-Q1=1.18; 95% CI=1.05-1.34; ptrend=0.007) from deep frying fats were also positively associated with ovarian cancer. Suggestive associations were reported for circulating elaidic (Odds Ratio comparing 3rd with 1st tertileT3-T1 = 1.39; 95% CI=0.99-1.94; ptrend=0.06) and α-linolenic acids (ORT3-T1=1.30; 95% CI=0.98-1.72; ptrend=0.06).Our results suggest that higher intakes and circulating levels of industrial trans elaidic acid, and higher intakes of linoleic acid and α-linolenic acid from deep frying fat, may be associated with greater risk of ovarian cancer.If causal, eliminating industrial trans fatty acids could offer a straightforward public health action for reducing ovarian cancer.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Huybrechts, Inge
|b 1
700 1 _ |a Biessy, Carine
|b 2
700 1 _ |a Dossus, Laure
|b 3
700 1 _ |a Aglago, Elom K
|b 4
700 1 _ |a Naudin, Sabine
|0 0000-0003-1049-6225
|b 5
700 1 _ |a Ferrari, Pietro
|b 6
700 1 _ |a Weiderpass, Elisabete
|0 0000-0003-2237-0128
|b 7
700 1 _ |a Tjonneland, Anne
|0 0000-0003-4385-2097
|b 8
700 1 _ |a Hansen, Louise
|b 9
700 1 _ |a Overvad, Kim
|b 10
700 1 _ |a Romana Mancini, Francesca
|0 0000-0003-2297-3869
|b 11
700 1 _ |a Boutron-Ruault, Marie-Christine
|0 0000-0002-5956-5693
|b 12
700 1 _ |a Kvaskoff, Marina
|0 0000-0002-4557-3772
|b 13
700 1 _ |a Turzanski-Fortner, Renée
|0 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2
|b 14
|u dkfz
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 15
|u dkfz
700 1 _ |a Schulze, Matthias B
|0 0000-0002-0830-5277
|b 16
700 1 _ |a Boing, Heiner
|b 17
700 1 _ |a Trichopoulou, Antonia
|b 18
700 1 _ |a Karakatsani, Anna
|0 0000-0002-3275-2026
|b 19
700 1 _ |a La Vecchia, Carlo
|0 0000-0003-1441-897X
|b 20
700 1 _ |a Benetou, Vassiliki
|0 0000-0002-0415-0386
|b 21
700 1 _ |a Masala, Giovanna
|0 0000-0002-5758-9069
|b 22
700 1 _ |a Krogh, Vittorio
|0 0000-0003-0122-8624
|b 23
700 1 _ |a Mattiello, Amalia
|b 24
700 1 _ |a Macciotta, Alessandra
|b 25
700 1 _ |a Gram, Inger T
|0 0000-0002-0031-4152
|b 26
700 1 _ |a Skeie, Guri
|0 0000-0003-2476-4251
|b 27
700 1 _ |a Quiros Garcia, Jose Ramon
|b 28
700 1 _ |a Agudo, Antonio
|b 29
700 1 _ |a Sanchez-Perez, Maria-Jose
|b 30
700 1 _ |a Chirlaque, Maria-Dolores
|b 31
700 1 _ |a Ardanaz, Eva
|0 0000-0001-8434-2013
|b 32
700 1 _ |a Gil, Leire
|0 0000-0001-6843-4460
|b 33
700 1 _ |a Sartor, Hanna
|0 0000-0002-1116-5199
|b 34
700 1 _ |a Drake, Isabel
|b 35
700 1 _ |a Idahl, Annika
|0 0000-0002-7865-4560
|b 36
700 1 _ |a Lundin, Eva A
|b 37
700 1 _ |a Aune, Dagfinn
|b 38
700 1 _ |a Ward, Heather A
|b 39
700 1 _ |a Merritt, Melissa A
|b 40
700 1 _ |a Allen, Naomi E
|0 0000-0003-1938-5038
|b 41
700 1 _ |a Gunter, Marc J
|b 42
700 1 _ |a Chajes, Veronique
|b 43
773 _ _ |a 10.1158/1055-9965.EPI-19-1477
|g p. cebp.1477.2019 -
|0 PERI:(DE-600)2036781-8
|n 9
|p 1739-1749
|t Cancer epidemiology, biomarkers & prevention
|v 29
|y 2020
|x 1538-7755
909 C O |o oai:inrepo02.dkfz.de:156859
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2020-01-17
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-01-17
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2020-01-17
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER EPIDEM BIOMAR : 2018
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-01-17
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CANCER EPIDEM BIOMAR : 2018
|d 2020-01-17
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21